Monocenter prospective registry to evaluate real life data of survival, treatment and consequences from changes of the WHO classification of Brain Tumors and molecular characteristics with regard to reclassification or prognosis in a German hospital - GLIO-REAL

Monocenter prospective registry to evaluate real life data of survival, treatment and consequences from changes of the WHO classification of Brain Tumors and molecular characteristics with regard to reclassification or prognosis in a German hospital - GLIO-REAL - GLIO-REAL Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028497

Enrollment

400

Registered

2022-03-09

Start date

2022-03-04

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71 C72

Interventions

Group 1: It will be collected all relevant diagnostic and therapeutic information until death

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: astrocytoma, glioma, oligodendroglioma, glioblastoma

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
survival in years	—

Secondary

Measure	Time frame
survival dependent to treatment, survival dependent to subgroups, reclassification due to molecular characteristics	—

Countries

Germany

Contacts

Public ContactJohannes Hoffmann

Universitätsklinik Innere Medizin - Onkologie, Pius Hospital, Universitätsmedizin Oldenburg

johannes.hoffmann@pius-hospital.de0441-229-1619

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026